協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/29 | 2,805 | 2,834 | 2,784 | 2,832 | +23 | +0.8% | 634,600 |
2020/12/28 | 2,793 | 2,836 | 2,780 | 2,809 | +66 | +2.4% | 716,800 |
2020/12/25 | 2,787 | 2,789 | 2,733 | 2,743 | -27 | -1% | 319,400 |
2020/12/24 | 2,754 | 2,776 | 2,735 | 2,770 | +7 | +0.3% | 473,100 |
2020/12/23 | 2,737 | 2,791 | 2,729 | 2,763 | +50 | +1.8% | 1,056,900 |
2020/12/22 | 2,683 | 2,725 | 2,680 | 2,713 | +27 | +1% | 713,400 |
2020/12/21 | 2,653 | 2,704 | 2,635 | 2,686 | +48 | +1.8% | 768,400 |
2020/12/18 | 2,645 | 2,652 | 2,623 | 2,638 | -11 | -0.4% | 1,424,400 |
2020/12/17 | 2,699 | 2,700 | 2,646 | 2,649 | -50 | -1.9% | 794,900 |
2020/12/16 | 2,740 | 2,754 | 2,675 | 2,699 | -35 | -1.3% | 845,500 |
2020/12/15 | 2,780 | 2,784 | 2,724 | 2,734 | -58 | -2.1% | 777,400 |
2020/12/14 | 2,827 | 2,845 | 2,789 | 2,792 | -51 | -1.8% | 842,000 |
2020/12/11 | 2,831 | 2,858 | 2,816 | 2,843 | +8 | +0.3% | 822,200 |
2020/12/10 | 2,831 | 2,844 | 2,820 | 2,835 | -15 | -0.5% | 404,500 |
2020/12/09 | 2,868 | 2,874 | 2,838 | 2,850 | -6 | -0.2% | 471,500 |
2020/12/08 | 2,882 | 2,882 | 2,840 | 2,856 | -33 | -1.1% | 504,300 |
2020/12/07 | 2,891 | 2,907 | 2,869 | 2,889 | +21 | +0.7% | 480,100 |
2020/12/04 | 2,849 | 2,888 | 2,844 | 2,868 | +2 | +0.1% | 506,700 |
2020/12/03 | 2,899 | 2,902 | 2,866 | 2,866 | -16 | -0.6% | 679,600 |
2020/12/02 | 2,895 | 2,904 | 2,853 | 2,882 | -7 | -0.2% | 699,400 |
2020/12/01 | 2,861 | 2,894 | 2,839 | 2,889 | +54 | +1.9% | 656,700 |
2020/11/30 | 2,901 | 2,916 | 2,803 | 2,835 | -45 | -1.6% | 1,769,100 |
2020/11/27 | 2,855 | 2,886 | 2,846 | 2,880 | +27 | +0.9% | 679,300 |
2020/11/26 | 2,815 | 2,860 | 2,792 | 2,853 | +45 | +1.6% | 591,200 |
2020/11/25 | 2,842 | 2,880 | 2,804 | 2,808 | -12 | -0.4% | 762,700 |
2020/11/24 | 2,781 | 2,827 | 2,761 | 2,820 | +72 | +2.6% | 846,900 |
2020/11/20 | 2,753 | 2,763 | 2,731 | 2,748 | -5 | -0.2% | 541,500 |
2020/11/19 | 2,772 | 2,776 | 2,729 | 2,753 | -47 | -1.7% | 959,300 |
2020/11/18 | 2,852 | 2,863 | 2,786 | 2,800 | -65 | -2.3% | 838,600 |
2020/11/17 | 2,897 | 2,897 | 2,849 | 2,865 | -47 | -1.6% | 842,000 |
2020/11/16 | 2,922 | 2,931 | 2,890 | 2,912 | -4 | -0.1% | 759,100 |
2020/11/13 | 2,939 | 2,953 | 2,903 | 2,916 | -34 | -1.2% | 1,039,700 |
2020/11/12 | 2,965 | 2,965 | 2,931 | 2,950 | +4 | +0.1% | 850,200 |
2020/11/11 | 2,904 | 2,965 | 2,892 | 2,946 | +76 | +2.6% | 1,048,000 |
2020/11/10 | 2,900 | 2,916 | 2,868 | 2,870 | -6 | -0.2% | 784,600 |
2020/11/09 | 2,837 | 2,893 | 2,824 | 2,876 | +51 | +1.8% | 713,800 |
2020/11/06 | 2,756 | 2,838 | 2,754 | 2,825 | +21 | +0.7% | 818,200 |
2020/11/05 | 2,735 | 2,823 | 2,715 | 2,804 | +110 | +4.1% | 1,359,400 |
2020/11/04 | 2,699 | 2,706 | 2,651 | 2,694 | +29 | +1.1% | 929,500 |
2020/11/02 | 2,590 | 2,666 | 2,559 | 2,665 | +75 | +2.9% | 1,028,100 |
2020/10/30 | 2,650 | 2,651 | 2,589 | 2,590 | -61 | -2.3% | 794,100 |
2020/10/29 | 2,663 | 2,680 | 2,638 | 2,651 | -20 | -0.7% | 833,200 |
2020/10/28 | 2,623 | 2,684 | 2,619 | 2,671 | +48 | +1.8% | 620,100 |
2020/10/27 | 2,609 | 2,627 | 2,574 | 2,623 | +4 | +0.2% | 504,300 |
2020/10/26 | 2,615 | 2,635 | 2,603 | 2,619 | +13 | +0.5% | 345,500 |
2020/10/23 | 2,646 | 2,652 | 2,606 | 2,606 | -19 | -0.7% | 471,000 |
2020/10/22 | 2,637 | 2,646 | 2,608 | 2,625 | -46 | -1.7% | 466,900 |
2020/10/21 | 2,658 | 2,695 | 2,638 | 2,671 | +20 | +0.8% | 800,300 |
2020/10/20 | 2,673 | 2,687 | 2,640 | 2,651 | -44 | -1.6% | 554,000 |
2020/10/19 | 2,717 | 2,719 | 2,681 | 2,695 | -2 | -0.1% | 577,700 |
951~
1000
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム